Six bioscience startups creating innovative solutions to improve regenerative medicine, spinal surgery, sleep health, medical payments, the food supply, and ear cleaning have been selected for the 2020 Flinn Foundation Bioscience Entrepreneurship Program.Continue reading
Author Archive: AZBio
Discount Tire Partners with TGen to Create a Personalized Screening and Prevention Plan for Cancer Risk
Pilot study to focus on family history of relevant diseases and genetic risk scoreContinue reading
Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine
Work with Biomedical Advanced Research and Development Authority (BARDA) will utilize Sanofi’s well-established recombinant technology platform to expedite a potential COVID-19 vaccine
Continue reading
Getting a head start – The Advantages of New Born Screening
The purpose of newborn screening is to detect potentially fatal or disabling conditions in newborns as early as possible, often before the infant displays any signs or symptoms of a disease or condition. Arizona Legislators and Patient Advocates are working together to ensure Arizona babies are tested for additional conditions where early intervention can make a world of difference for patients and their families. Continue reading
AZBio Begins Data Gathering for Biennial Workforce Report
Talent is essential for every industry. Every two years, AZBio, in partnership with the Coalition of State Bioscience Institutes (CSBI) takes a look at the talent we have and the talent we need to grow great companies that make life better. Now is the time when your company can join the study.Continue reading
Unique Ways to Save on AZBio Membership
Is it time to renew your AZBio Membership? Did you know that by signing up for AZBio Programs with BIO Business Solutions®, many members will save MORE than the cost of their annual membership dues when they use these programs for AZBio Members?Continue reading
Skysong Innovations Completes Licensing Agreement with ASU Spinout OncoMyx Therapeutics
Immunotherapy company backed by $25 million in Series A financing is developing cancer treatments based on novel ASU technology. OncoMyx Therapeutics is an ASU spinout company founded on the myxoma virus (MYXV) platform.
Becoming Part of the Process
The 2020 Arizona Legislative Session is in full swing. Take a look at what it can mean to you.Continue reading
UArizona Cancer Center Receives $6.9M Grant for Skin Cancer Prevention Study
With funding from the National Cancer Institute, a team of researchers at the University of Arizona Cancer Center is seeking effective preventive and therapeutic strategies to reduce the risk of non-melanoma skin cancer, like squamous cell carcinoma of the skin.Continue reading
BIO’s Right Mix Matters Campaign focuses on Diversity and Inclusion
The “Right Mix Matters” campaign was launched to provide specific tools to accelerate gender, racial, ethnic and LGBTQ representation on biotech company boards, in C-suites and in functional leadership positions.